A molecular clamp is a polypeptide used to maintain the shape of proteins in some experimental vaccines. On a virus, pre-fusion proteins on their surface provide an attractive target for an immune reaction. From Wikipedia
The agreement bolsters Sanofi’s non-mRNA vaccine portfolio by adding combination candidates that use a protein-stabilization platform ahead of a Q4 2025 closing.
